Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 5:13 pm Purchase |
2024-12-31 | 13G | ABVC BioPharma, Inc. ABVC |
Lind Global Fund II LP | 1,325,000 9.900% |
175,000 (+15.22%) |
Filing History |
| 2024-11-14 7:33 pm Purchase |
2024-09-30 | 13G | ABVC BioPharma, Inc. ABVC |
Lind Global Fund II LP | 1,150,000 9.900% |
380,000 (+49.35%) |
Filing History |
| 2024-02-13 7:59 pm Purchase |
2023-12-31 | 13G | ABVC BioPharma, Inc. ABVC |
Lind Global Fund II LP | 770,000 9.900% |
770,000 (New Position) |
Filing History |
| 2023-08-07 4:01 pm Purchase |
2023-07-28 | 13G | ABVC BioPharma, Inc. ABVC |
Lind Global Fund II LP | 385,000 9.900% |
385,000 (New Position) |
Filing History |
| 2022-07-12 5:00 pm Purchase |
2022-05-20 | 13D | ABVC BioPharma, Inc. ABVC |
Jiang Shuling | 790,881 24.500% |
790,881 (New Position) |
Filing |